50712-67-9

Basic information

• Product Name: 2-(bromomethyl)-4-chlorobenzonitrile
• Synonyms: 2-(bromomethyl)-4-chlorobenzonitrile
• CAS NO: 50712-67-9
• Molecular Formula: C₈H₅BrClN
• Molecular Weight: 230.489
• Mol File: 50712-67-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(bromomethyl)-4-chlorobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(bromomethyl)-4-chlorobenzonitrile(50712-67-9)
• EPA Substance Registry System: 2-(bromomethyl)-4-chlorobenzonitrile(50712-67-9)

Safety Data

• Hazardous Substances Data: 50712-67-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-(bromomethyl)-4-chlorobenzonitrile is used as a synthetic intermediate for the production of various pharmaceuticals. Its reactivity with nucleophiles allows for the creation of a wide range of drug molecules, contributing to the development of new medications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(bromomethyl)-4-chlorobenzonitrile serves as a key intermediate in the synthesis of agrochemicals. Its role in creating specific chemical structures is essential for the development of effective pesticides and other agricultural products.
Used in Dye Production:
2-(bromomethyl)-4-chlorobenzonitrile is used as a chemical intermediate in the production of dyes. 2-(bromomethyl)-4-chlorobenzonitrile's structure lends itself to the creation of diverse dye molecules, which are crucial for the textile and other industries that rely on colorants.
Used in Organic Compound Synthesis:
Beyond its applications in pharmaceuticals, agrochemicals, and dyes, 2-(bromomethyl)-4-chlorobenzonitrile is also used in the synthesis of other organic compounds. Its versatility in chemical reactions makes it a valuable component in the creation of a broad spectrum of organic molecules for various applications.
Safety Note:
It is important to handle 2-(bromomethyl)-4-chlorobenzonitrile with care due to its toxicity. It can cause skin and eye irritation and poses other health hazards if not properly managed. Proper safety measures and personal protective equipment are essential when working with 2-(bromomethyl)-4-chlorobenzonitrile.

Upstream product

• 50712-68-0 4-chloro-2-methylbenzonitrile 
• 34241-39-9 azobisisobutyronitrile 

Downstream Products

• 1009633-59-3 C₂₂H₃₂ClN₃O₂ 
• 1009633-60-6 C₂₁H₃₀ClN₃O₂ 
• 1009633-64-0 C₂₂H₃₀ClN₃O₂ 
• 1009633-66-2 C₂₃H₃₂ClN₃O₂ 
• 1027346-03-7 C₁₉H₂₆ClN₃O₂ 
• 1027344-63-3 C₂₂H₃₂ClN₃O₂ 
• 1027346-09-3 C₁₈H₂₄ClN₃O₂ 
• 1027346-16-2 C₂₀H₂₈ClN₃O₂ 
• 1009633-79-7 C₂₂H₃₂ClN₃O₂ 
• 1009633-67-3 C₂₄H₂₈ClN₃O₂ 
• 1009633-52-6 C₁₉H₂₆ClN₃O₂ 
• 1009633-55-9 C₂₀H₂₈ClN₃O₂ 
• 1009633-57-1 C₂₁H₃₀ClN₃O₂ 
• 77532-89-9 4-chloro-2-formyl-benzonitrile 

Relevant articles and documents

Palladium-Catalyzed Tandem Carbonylative Diels-Alder Reaction for Construction of Bridged Polycyclic Skeletons

A palladium-catalyzed tandem carbonylative lactonization and Diels-Alder cycloaddition reaction between aldehyde-tethered benzylhalides and alkenes has been developed. A range of alkenes and aldehyde-tethered benzylhalides bearing different substituents can be successfully transformed into the corresponding bridged polycyclic compounds in good yields. This strategy provides a unique approach to complex lactone-containing bridged polycyclic compounds.

Annulation of o-Quinodimethanes through N-Heterocyclic Carbene Catalysis for the Synthesis of 1-Isochromanones

The activation of 2-(bromomethyl)benzaldehydes using N-heterocyclic carbenes represents a novel approach to the generation of o-quinodimethane (o-QDM) intermediates. Coupling with ketones such as phenylglyoxylates, isatins, or trifluoromethyl ketones via [4 + 2] annulation gives access to functionalized 1-isochromanones.

PYRAZOLOPYRIDINE PYRAZOLOPYRIMIDINE AND RELATED COMPOUNDS

In one aspect this invention relates generally to compounds of Formula: and sub-formulas thereof, or a tautomer of each thereof, a pharmaceutically acceptable salt of each thereof, or a pharmaceutically acceptable solvate of each of the foregoing, where X1, L1, L3, and R3 are described herein.

CYCLIC IMIDATE LIGANDS

The present invention relates to a use of a cyclic imidate as a ligand for catalysis in which the ligand contains sub-structure (Y) as a minimal structural motive, wherein the carbon atoms and the nitrogen atom can be optionally substituted by a chemical substituent.

Efficient one-step synthesis of chiral bidentate oxazoline-alcohol ligands via a cyclic imidate ester rearrangement

Various chiral bidentate oxazoline-alcohol ligands were obtained in a straightforward one-step synthesis via a cyclic imidate ester rearrangement. These chiral ligands were tested and compared in asymmetric diethylzinc additions to aldehydes resulting in

Discovery of a series of aminopiperidines as novel iNOS inhibitors

Nitric oxide (NO), a mediator of various physiological and pathophysiological processes, is synthesized by three isozymes of nitric oxide synthase (NOS). Potential candidate clinical drugs should be devoid of inhibitory activity against endothelial NOS (eNOS), since eNOS plays an important role in maintaining normal blood pressure and flow. A new series of aminopiperidines as potent inhibitors of iNOS were identified from a HTS lead. From this study, we identified compound 33 as a potent iNOS inhibitor, with >25-fold selectivity over eNOS and 16-fold selectivity over nNOS.

CYCLIC AMIDINES USEFUL AS NMDA NR2B ANTAGONISTS

The invention encompasses novel compounds of Formula I as well as a method of treating NMDA mediated diseases comprising administration to a patient in need of such treatment a non-toxic amount of a compound of Formula I effective to block the NMDA NR2B r